Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

A Phase III global multi-regional clinical trial of CS2009 in colorectal cancer

Trial Profile

A Phase III global multi-regional clinical trial of CS2009 in colorectal cancer

Status: Planning
Phase of Trial: Phase III

Latest Information Update: 24 Jun 2026

Price :
$35 *
Note:
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs CS 2009 (Primary)
  • Indications Colorectal cancer
  • Focus Registrational; Therapeutic Use

Most Recent Events

  • 11 Jun 2026 According to a CStone media release, company to discuss this trial protocol in Q4 2026.
  • 20 Apr 2026 New trial record
  • 26 Mar 2026 According to CStone media release, the company plans to initiate the first set of Phase III global multi-regional clinical trials (MRCTs) for CS2009 by the end of 2026, focusing on indications including NSCLC, CRC, and SCLC. The company is currently into partnership discussions with several global multinational pharmaceutical companies and aim to initiate multiple Phase III MRCT by the end of 2026.

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top